Long-term persistence of T cell memory to HBsAg after hepatitis A vaccination

World Journal of Gastroenterology

Volumn 10, Issue 2, 2004, Pages 260-263

  Wang, Ru Xiang ^a   Boland, Greet J ^b   Van Hattum, Jan ^b   De Gast, Gijsbert C ^c  

^a Shenyang Center for Disease Control and Prevention   (China)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE;

ADULT; ARTICLE; BLOOD SAMPLING; CELL CULTURE; CELL DIVISION; CELL ISOLATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOLOGY; FEMALE; HEALTH CARE PERSONNEL; HEPATITIS B; HUMAN; HUMAN EXPERIMENT; IMMUNIZATION; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; IN VITRO STUDY; LONG TERM CARE; LYMPHOCYTE PROLIFERATION; MALE; MEMORY CELL; MONONUCLEAR CELL; NETHERLANDS; PERIPHERAL BLOOD MONONUCLEAR CELL; T LYMPHOCYTE; VACCINATION;

EID: 1042304316     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v10.i2.260     Document Type: Article

References (33)

1. Liao SS, Li RC, Li H, Yang JY, Zeng XJ, Gong J, Wang SS, Li YP, Zhang KL. Long-term efficacy of plasma-derived hepatitis B vacine among Chinese children: A 12-year follow-up study. World J Gastroenterol 1999;5:165-166
2. Li H, Li RC, Liao SS, Yang JY, Zeng XJ, Wang SS. Persistence of hepatitis B vaccine immune protection and response to hepatitis B booster immunization. World J Gastroenterol 1998; 4: 493-496
3. Kojouharova M, Teoharov P, Bahtchevanova T, Maeva I, Eginlian A, Deneva M. Safety and immunogenicity of a yeast-derived recombinat hepatitis B vaccine in Bulgarian newborns. Infection 2001; 29: 342-344
4. Rendi-Wagner P, Kundi M, Stemberger H, Wiedermann G, Holzmann H, Hofer M, Wiesinger K, Kollaritsch H. Antibody-response to three recombinant hepatitis B vaccines: Comparative evaluation of multicenter travel-clinic based experience. Vaccine 2001; 19: 2055-2060
5. Ozaki T, Mochizuki H, Ichikawa Y, Fukuzawa Y, Yoshida S, Morito M. Persistence of hepatitis B surface antibody levels after vaccination with a recombinant hepatitis B vaccine: A 3-year follow-up study. J Oral Sci 2000; 42: 147-150
6. Jain A, Mathur US, Jandwani P, Gupta RK, Kumar V, Kar P. A multicentric evaluation of recombinant DNA hepatitis B vaccine of Cuban origin. Trop Gastroenterol 2000; 21: 14-17
7. Al-Faleh FZ, Al-Jeffri M,, Ramia S, Al-Rashed R, Arif M, Rezeig M, Al-Toraif I, Bakhsh M, Mishkkhas A, Makki O, Al-Freihi H, Mirdad S, AlJuma A, Yasin T, Al-Swailem A, Ayoola A. Seroepidemiology of hepatitis B virus infection in Saudi children 8 years after a mass hepatitis B vaccination programme. J Infect 1999; 38: 167-170
8. Li H, Li RC, Liao SS, Gong J, Zeng XJ, Li YP. Long-term effectiveness of infancy low-dose hepatitis B vaccine immunization in Zhuang minority area in China. World Gastroenterol 1999; 5: 122-124
9. Liu HB, Meng ZD, Ma JC, Han CQ, Zhang YL, Xing ZC, Zhang YW, Liu YZ, Cao HL. A 12-year cohort study on the efficacy of plasma-derived hepatitis B vaccine in rural newborns. World J Gastroenterol 2000; 6: 381-383
10. Li H, Wang L, Wang SS, Gong J, Zeng XJ, Li RC, Nong Y, Huang YK, Chen XR, Huang ZN. Research on optimal immunization strategies for hepatitis B in different endemic areas in China. World J Gastroenterol 2000; 6: 392-394
11. Zeng XJ, Yang GH, Liao SS, Chen AP, Tan J, Huang ZJ, Li H. Survey of coverage, strategy and cost of hepatitis B vaccination in rural and urban areas of China. World J Gastroenterol 1999; 5: 320-323
12. Shokri F, Jafarzadeh A. high seroprotection rate induced by low doses of a recombinant hepatitis B vaccine in healthy Iranian neonates. Vaccine 2001; 19: 4544-4548
13. Trivello R, Chiaramonte M, Ngatchu T, Baldo V, Majori S, Moschen ME, Simoncello I, Renzulli G, Naccarato R. Persistence of anti-HBs antibodies in health care personnel vaccinated with plasma-derived hepatitis B vaccine and response to recombinant DNA HB booster vaccine. Vaccine 1995; 13: 139-141
14. Whittle HC, Maine N, Pikington J, Mendy M, Fortuin M, Bunn J, Allison L, Howard C, Hall A. Long-term efficacy of continuing hepatitis B vaccination in infancy in two Gambian villages. Lancet 1995; 345: 1089-1092
15. Jilg W, Schmidt M, Deinhardt F. Decline of anti-HBs after hepatitis B vaccination and timing of revaccination. Lancet 1990; 335: 173-174
16. Wismans PJ, Van Hattum J, Mudde GC, Endeman HJ, Poel J, De Gast GC. Is booster injection with hepatitis B vaccination necessary in healthy responders? A study of the immune response. J Hepatol 1988; 1: 1-5
17. Wood RC, MacDonald KL, White KE, Hedberg CW, Hanson M, Osterholm MT. Risk factors for lack of detectable antibody following hepatitis B vaccination of Minnesota health care workers. JAMA 1993; 270: 2935-2939
18. Roome AJ, Walsh SJ, Cartter ML, Hadler JL. Hepatitis B vaccine responsiveness in the Connecticut public safety personnel. JAMA 1993; 270: 2931-2934
19. Watson B, West DJ, Chilkatowsky A, Piercy S, Ioli VA. Persistence of immunologic memory for 13 years in recipients of a recombinant hepatitis B vaccine. Vaccine 2001; 19: 3164-3168
20. Wistrom J, Ahlm C, Lundberg S, Settergren B, Tarnvik A. Booster vaccination with recombinant hepatitis B vaccine four years after priming with one single dose. Vaccine 1999; 17: 2162-2165
21. Banatvala J, Van Damme P, Oehen S. Lifelong protection against hepatitis B: The role of vaccine immunogenicity in immune memory. Vaccine 2000; 19: 877-885
22. Garcia Llop L, Asensi Alcoverro A, Coll Mas P, Ramada Benedito MA, Grafia Juan C. Anti-HBs titers after a vaccination program in children and adolescents. Should a booster dose be given? An Esp Pediatr 2001; 54: 32-37
23. Huang LM, Chiang BL, Lee CY, Lee PI, Chi WK, Chang MH. Long-term response to hepatitis B vaccination and response to booster in children born to mothers with hepatitis B e antigen. Hepatology 1999; 29: 954-959
24. Leroux-Roels G, Van Hecke E, Michielsen W, Voet P, Hauser P, Petre J. Correlation between in vivo humoral and in vitro cellular immune responses following immunization with hepatitis B surface antigen (HBsAg) vaccines. Vaccine 1994; 12: 812-815
25. Are booster immunisations needed for lifelong hepatitis B immunity? European Consensus Group on Hepatitis B Immunity. Lancet 2000; 355: 561-565
26. De Gast GC, Houwen B, Nieweg HO. Specific lymphocyte stimulation by purified heat-inactivated hepatitis B antigen. Br Med J 1973; 4: 707-709
27. Fernan A, Cayzer CJ, Cooksley WG. HBsAg-induced antigen-specific T and B lymphocyte response in chronic hepatitis B virus carriers and immune individuals. Clin Exp Immunol 1989; 76: 222-226
28. Ferrari G, Penna A, Bertoletti A, Cavalli A, Valli A, Schianchi C, Fiaccadori F. The preS1 antigen of hepatitis b virus is highly immunogenic at T cell level in man. J Clin Invest 1989; 84: 1314-1319
29. Cupps TR, Tibbles J, Hurni WM, Miller WJ, Ellis RW, Milich D, Wetter N. In vitro T cell immune responses to the PreS2 antigen of the hepatitis B virus envelope protein in PreS2+S vaccine recipients. J Immunol 1993; 151: 3353-3360
30. Deulofeut H, Iglesias A, Mikeal N, Bing DH, Awdeh Z, Yunis J, Marcus-Bagley D, Kruskall MS, Alper CA, Yunis EJ. Cellular recognition and HLA restriction of a midsequence HBsAGg peptide in hepatitis B vaccinated individuals. Mol Immunol 1993; 30: 941-948
31. Degrassi A, Mariani E, Honorati MC, Roda P, Miniero R, Capelli M, Faccini A. Cellular response and anti-HBs synthesis in vitro after vaccination with yeast-derived recombinant hepatitis B vaccine. Vaccine 1992; 10: 617-621
32. Wismans PJ, van Hattum J, de Gast GC, Bouter KP, Diepersloot RJ, Maikoe T, Mudde GC. A prospective study of in vitro anti-HBs producing B cells (spot-ELISA) following primary and supplementary vaccination with a recombinant hepatitis B vaccine in insulin dependent diabetic patients and matched controls. J Med Virol 1991; 35: 216-222
33. Wismans PJ, van Hattum J, de Gast GC, Endeman HJ, Poel J, Stolk B, Maikoe T, Mudde GC. The spot-ELISA: A sensitive in vitro method to study the immune response to hepatitis B surface antigen. Clin Exp Immunol 1989; 78: 75-79